Adenosine A1 receptor-mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices
Adenosine A1 receptor-mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices
复制标题
DOI:
10.1111/epi.13360
复制
发表时间:
2016-05-01
期刊:
影响因子:
5.6
通讯作者:
Heinemann, Uwe
中科院分区:
文献类型:
--
作者:
Klaft, Zin-Juan;Hollnagel, Jan-Oliver;Heinemann, Uwe
Objective: The need for alternative pharmacologic strategies in treatment of epilepsies is pressing for about 30% of patients with epilepsy who do not experience satisfactory seizure control with present treatments. In temporal lobe epilepsy (TLE) even up to 80% of patients are pharmacoresistant, and surgical resection of the ictogenic tissue is only possible for a minority of TLE patients. In this study we investigate purinergic modulation of drug-resistant seizure-like events (SLEs) in human temporal cortex slices.Methods: Layer V/VI field potentials from a total of 77 neocortical slices from 17 pharmacoresistant patients were recorded to monitor SLEs induced by application of 8 mM[K+] and 50 lM bicuculline.Results: Activating A(1) receptors with a specific agonist completely suppressed SLEs in 73% of human temporal cortex slices. In the remaining slices, incidence of SLEs was markedly reduced. Because a subportion of slices can be pharmacosensitive, we tested effects of an A(1) agonist, in slices insensitive to a high dose of carbamazepine (50 lM). Also in these cases the A(1) agonist was equally efficient. Moreover, ATP and adenosine blocked or modulated SLEs, an effect mediated not by P2 receptors but rather by adenosine A(1) receptors.Significance: Selective activation of A(1) receptors mediates a strong anticonvulsant action in human neocortical slices from pharmacoresistant patients. We propose that our human slice model of seizure-like activity is a feasible option for future studies investigating new antiepileptic drug (AED) candidates.